检索

标题
作者
Analysis of the structure of comorbidities and pharmacotherapy in patients with a combination of atrial fibrillation and coronary heart disease
Dubinina A., Kochetkov A., Vorobieva А., Eremina S., Mirzaev K., Ostroumova O.
Possibilities of screening for asymptomatic atrial fibrillation in clinical practice
Stepanenko I., Sopova D., Salukhov V., Zaslavskaya E., Tarasov V., Novikov I.
Modern treatment options for arrhythmias: focus on propafenone
Tarzimanova A.
Atrial fibrillation and anemia: what do we know and how to approach therapy?
Polyakova O., Dubinina A., Telkova S., Isaakyan Y., Ostroumova O.
Modern principles of antiarrhythmic therapy of atrial fibrillation
Tarzimanova A.
On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy
Ostroumova O., Dubinina A., De V., Kochetkov A., Dashabylova V., Eremina S., Klepikova M.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.
Drug-induced atrial fibrillation/flutter associated with drugs affecting the central nervous system
Ostroumova O., Cherniaeva M., Maslennikova O., Zykova O., Komarova A., Sychev D.
MODERN FORMS OF DRUG TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION AND ATRIAL FLUTTER
Volkov V., Dotsenko Y., Kiryushina I., Volkov V., Dotsenko Y., Kiryushina I.
Factors determining the efficiency and rate of sinus rhythm recovery in pharmacological cardioversion using injectable propafenone and amiodarone
Tarasov A., Redka A., Shilkina E.
ANTICOAGULATION WITH DIRECT ORAL ANTICOAGULANTS BEYOND CLINICAL RECOMMENDATIONS: DIFFICULT CHOICE OF CLINICIANS AND PERSONALIZED APPROACH TO TREATMENT
Napalkov D., Sokolova A.
INGIBITOR FAKTORA Kha SVERTYVAEMOSTI KROVI RIVAROKSABAN PRI MERTsATEL'NOY ARITMII
Zotova I., Zateyshchikov D.
role of sotalol in the treatment of heart rhythm disturbances: modern approaches
Sulimov V., Napalkov D., Sulimov V., Napalkov D.
MANAGEMENT OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE SETTINGS OF ANTICOAGULANT THERAPY CONTROL OFFICE: PROLONGED EFFECTIVE AND SAFE USE OF ANTICOAGULATION
Sokolova A., Tsarev I., Napalkov D., Sulimov V.
AMIODARON I DISFUNKTsIYa ShchITOVIDNOY ZhELEZY
Pavlova T., Bulanova E., Duplyakov D.
Modern principles of maintaining sinus rhythm in atrial fibrillation
Tarzimanova A.
Novye oral'nye antikoagulyanty v profilaktike i lechenii venoznykh trombozov i tromboemboliy: fokus na rivaroksaban
Glezer M.
N-3 POLINENASYShchENNYE ZhIRNYE KISLOTY V FARMAKOTERAPII FIBRILLYaTsII PREDSERDIY
Moiseev S.
Modern methods of treatment of elderly patients with chronic heart failure: a literature review
Kurochkina O., Baranov A., Sazhina A., Bogomolov A.
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
Ostroumova O., Kochetkov A., Batyukina S., Lyakhova N.
PROFILAKTIKA TROMBOEMBOLIChESKIKh OSLOZhNENIY U PATsIENTOV S FIBRILLYaTsIEY PREDSERDIY
Morozova T., Andrushchishina T.
DABIGATRAN: PROSPECTS FOR CLINICAL APPLICATION
Zateyshchikov D., Zotova I., Zateyshcikov D., Zotova I.
QRS complex fragmentation in ST-segment elevation myocardial infarction: a clinical case
Gordeev I., Volov N., Arefiev M., Ilchenko R.
Sovremennye vozmozhnosti profilaktiki insul'tov u bol'nykh fibrillyatsiey predserdiy
Baryshnikova G.
ATRIAL FIBRILLATION ASSOCIATED WITH ARTERIAL HYPERTENSION
Volkov V., Volkov V.
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A., Prikolota O., Prikolota A., Mikhailichenko E., Golodnikov I., Bagriy O., Kotova K.
Prediction of the probability of hemorrhagic transformation to clarify the possible timing of initiation of anticoagulant therapy in patients with ischemic stroke and atrial fibrillation
Kalinin M.
Individualizirovannaya antitromboticheskaya terapiya pri fibrillyatsii predserdiy
Ashikhmin Y., Shchekochikhin D.
Features of the management and follow-up of a "difficult" comorbid elderly patient with COVID-19 complications: a clinical case
Tarantsova A.
RISK FACTORS FOR CEREBROVASCULAR DISEASES IN NEUROGERIATRY
Novikova L., Akopyan A., Mustafin K., Khabibrakhmanova N., Kayumova I.
Profilaktika tromboembolicheskikh oslozhneniy u patsientov s khronicheskoy serdechnoy nedostatochnost'yu
Napalkov D., Sokolova A., Zhilenko A.
Antihypertensive therapy in patients with paroxysmal form of atrial fibrillation: is drug selection important?
Romanova E., Kirichenko A., Romanova E., Kirichenko A.
Antiarrhythmic therapy for atrial fibrillation in patients with the novel SARS-CoV-2 coronavirus infection: how to make the right choice?
Tarzimanova A., Bykova E.
CHANGES IN ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION ON THE BACKGROUND OF ANTICOAGULANT THERAPY AFTER CARDIOEMBOLIC STROKE IN PATIENTS WITH ATRIAL FIBRILLATION
Zolotovskaya I., Davydkin I.
Preduprezhdenie tromboembolii u bol'nykh fibrillyatsiey predserdiy
Kanorskiy S.
Influence of renin-angiotensin-aldosterone system blockade on atrial fibrillation course
Romanova E., Kirichenko A., Romanova E., Kirichenko A.
1 - 36 的 36 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##